Hyris is driven by a vision to offer its clients an integrated testing solution that incorporates all the elements needed to deploy a network of biosensing units: any environment, any field.
The company is based on a product excellence strategy, delivering significant advantages to its clients and allowing a much larger cohort of users to deploy genetic testing solutions for the medical, veterinary and agrofood industries.
Clients that wish to execute specific genetic tests may choose from an increasing number of end user solutions the one that fits their need. All of these are suitable for both experienced personnel and front line operators.
Partners that require customized development can use the Hyris platform to their advantage, implementing and deploying specifically targeted solutions.
Hyris’ partners and management contribute to the company’s effort to build world-class client centered solutions with relevant experiences in the fields of:
Hyris’ investors include professionals with a long and successful track record in financial management, M&A, tech companies. The company is engaged with a number of world-class corporations and partners in the joint development of targeted testing solutions.